Business
GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board
GB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Welcomes Dr. Zoltan Mari, A Nationally Recognized Expert on the Study and Treatment of Parkinson's Disease to Their Scientific Advisory Board\nPR Newswire\nLAS VEGAS, Jan. 25, 2018\n\n\n\nLAS VEGAS, Jan. 25, 2018 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) welcomes Dr. Zoltan Mari, Section Head of the Nevada Movement Disorders Program and Lee Pascal Parkinson's Disease Scholar at Cleveland Clinic Lou Ruvo Center for Brain Health and a Clinical Professor of Neurology at the University of Nevada, Las Vegas, to its recently relaunched Scientific Advisory Board. Dr. Mari is a renowned expert of clinical research on Parkinson's disease and movement disorders, who is willing to offer his guidance on GB Sciences' Parkinson's disease therapy program.\n\nBefore moving to Las Vegas in 2017, Dr. Mari had served as the Director of the Parkinson's and Movement Disorder Center at Johns Hopkins University and as the Director of the National Parkinson Foundation Center of Excellence, also at Johns Hopkins University. Dr. Mari has published 70 peer-reviewed papers, authored multiple book chapters, and founded and directed many nationally recognized CME programs.  He is a co-founder of Neuraly, Inc., which is developing a revolutionary disease modifying treatment for Parkinson's disease, and he is a co-author on a patent regarding the use of transcranial direct current stimulation in Parkinson's disease. \n\n\"By accepting our invitation to join, Dr. Mari brings world-class experience in the clinical study of Parkinson's disease and movement disorders to GB Sciences' Scientific Advisory Board,\" explains Dr. Andrea Small Howard, Chief Science Officer of GB Sciences, Inc. \"Dr. Mari shares our philosophy that Parkinson's patients should be given access to individualized treatment options under the direction of well-qualified medical professionals. In additio...